SCIENTIFIC PROGRAMME
SESSION I
BIOLOGY OF B-CELL
PRECURSOR ALL
SESSION II
BIOLOGY OF T-CELL ALL
SESSION III
MINIMAL RESIDUAL
DISEASE MONITORING
SESSION IV
INDIVIDUALIZED
MANAGEMENT OF ALL
SESSION V
NEW ADVANCES IN ALL
SESSION VI
CAR T-CELLS &
ALLOGENEIC HSCT
SESSION VII
FRONTLINE
INCORPORATION OF
BITES AND ADCS
SESSION VIII
T-CELL ALL AND
LYMPHOBLASTIC
LYMPHOMA
SESSION IX
PH AND PH-LIKE ALL
SELECTED ABSTRACTS
FOR AN ORAL
PRESENTATION
SELECTED ABSTRACTS
AS E-POSTERS
DISCLOSURES
2nd Translational Research Conference
ACUTE LYMPHOBLASTIC LEUKAEMIA
E-CONFERENCE - #ESHALL2021
May 7-9, 2021
Chairs: Jan Cools, Hervé Dombret, Adele Fielding, Mark Litzow
GENERAL INFORMATION
On demand Programme: April 27 – June 9, 2021
Live Programme: May 7-9, 2021
E-Conference platform: https://acute-lymphoblastic-leukaemia-2021.esh.live/
Copyrights
E-Conference participants are requested to treat the information presented during ESH meetings as privileged
communication.
Presentation of data during ESH E-Conferences does not constitute publication in the sense of patent law and
the data presented therefore retains unpublished status.
Ask the faculty:
The E-Conference platform allows you to submit your question online.
Simply use the “ask a question” field when viewing the presentations / discussions (please quit the full screen
mode to be able to submit your question)
Twitter:
Join the conversation on social media using the E-Conference hashtag: #ESHALL2021
CME Accreditation:
The programme of the ESH Translational Research E-Conference on Acute Lymphoblastic Leukaemia 2021 has
been reviewed and approved for CME accreditation by the European Board for Accreditation in Haematology
(EBAH). The EHA-CME Unit has approved this educational activity for a maximum number of 16 CME credits.
Each physician should only claim credits for time that she/he actually spent in the educational activity.
The Translational Research E-Conference on Acute Lymphoblastic Leukaemia 2021 is committed to providing
unbiased, balanced and objective educational and scientific programmes. In accordance with EBAH guidelines,
all planners and speakers are asked to provide disclosures of their relevant financial relationships, which are
available for audience review via a slide presentation. The CME provider has a mechanism in place to identify
and resolve any conflicts of interest prior to the start of each presentation. Audience members will be asked to
assess each presentation for the presence/absence of commercial bias.